Packaging
Annual Meeting of the PDA: Gerresheimer provides information about syringe systems for biotech drugs
Thursday 17. April 2008 - Lecture and drug-delivery display in Colorado Springs, USA
Baked-on siliconisation: a process of interest for cartridges, vials and ampoules as well
The Annual Meeting of the Parenteral Drug Association (PDA) is one of the most prestigious events for pharmaceutical and medical practitioners – even beyond the borders of the USA. On 14 and 15 April 2008 it is taking place in Colorado Springs, and this time the Gerresheimer Group will again be involved in the content of the meeting. In its display (Stand 214) and a lecture the focus is on the very latest developments for injection systems. In addition, the Group exhibits highlights from its individual range of medical plastic systems.
At the PDA meeting a self-defining interest group concentrates on prefilled syringes. Increasingly important factors in this field are the stability and reactivity of certain injection substances – particularly biopharmaceutics – above all with regard to the various techno¬logies for interior siliconisation, which give the syringe wall the necessary slide characteristics and use significantly reduced silicone quantities. In a highly informative lecture, Gerresheimer Bünde explains the interrelationships and introduces participants to highly-advanced technological processes. Dr. Arno Fries, who is responsible in Gerresheimer Bünde for sales of syringe systems in North America and for worldwide product management of this category, talks about the “Stabilisation of sensitive drugs through baked-on sili¬conisation of glass containers”.
The subject of siliconisation is moreover of interest not only for syringes but also for highly advanced cartridges, injection vials and ampoules, with which Gerresheimer rounds off its display of pharmaceutical tubular-glass products. It is obvious however that syringe systems will attract special attention in this presentation: with RTF (Ready to Fill) syringes supplied already sterilised, and with multi-function accessories such as the Rigid Needle Shield (RNS), the Tamper Evident Luerlock Closure (TELC) and the Backstop, the company represents leading categories in syringe development. “We deal very intensively with all aspects of relevance to syringe systems across the board and have therefore achieved decisive progress: from the production technologies through to tailor-made surface-treatment processes and safety and convenience in practical use”, says Burkhard Lingenberg, Marketing and Communication Director for the Gerresheimer Group: “The market appreciates such commitment.”
The Group is also active as a competent partner in the customer-specific project business with medical plastic systems, which it has in the past restricted primarily to Europe but is now systematically globalising. In Colorado Springs it presents a small but revealing sample of this equally comprehensive service spectrum. Sophisticated inhalation appliances, insulin pen systems and disposables like those which can be seen in the exhibition are developed and realised by Gerresheimer from A to Z.